Jones William Benton
Insider CIK 1664506 · CRVS VP Pharmaceutical Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2025-12-04 | 2025-12-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | M Exercise deriv | 2025-06-04 | 2025-06-06 | 19,357 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | M Exercise | 2025-06-04 | 2025-06-06 | 19,357 | $3.50 | $67.7K | 173,130 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-12-20 | 2024-12-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy deriv | 2024-05-06 | 2024-05-07 | 19,357 | — | $0 | 19,357 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2024-05-06 | 2024-05-07 | 20,000 | $1.73 | $34.6K | 153,773 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-12-20 | 2022-12-20 | 20,000 | $0.79 | $15.8K | 133,773 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-12-16 | 2020-12-17 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-12-12 | 2019-12-16 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-12-12 | 2018-12-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-12-13 | 2017-12-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-03-22 | 2016-03-24 | 60,000 | — | $0 | 60,000 | SEC↗ |